recall
saveSandoz Inc recall (Cls II)
September 24, 2025updated 6mo ago
community read0 votes
Cyclophosphamide Injection 500 mg/5 mL (100 mg/mL), Hazardous Drug, Rx Only, Sterile, 5mL Multiple Dose Vial, Manufactured in Austria by Fareva Unterach GmbH for Sandoz Inc., Princeton, NJ 08540, Product of India, Vial NDC# 0781-3528-75, Carton NDC# 0781-3528-10. — Reason: cGMP deviations: Temperature excursion during transportation. — Status: Ongoing
view source ↗Data sources
last refreshed 17m ago
Found something off?
same company · ±60 days · 6
- approvalRITALIN LA: RITALIN LA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvalAZSTARYS (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvalLEUPROLIDE ACETATE: LEUPROLIDE ACETATE — FDA approvalSep 23, 2025
- approvaldexmethylphenidate hydrochloride ER: FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE) — FDA approvalSep 23, 2025
- approvalsuccharated ferric oxide: IRON SUCROSE — FDA approvalSep 22, 2025
- approvalPANTOPRAZOLE SODIUM: PANTOPRAZOLE SODIUM — FDA approvalOct 1, 2025
🐶 often sniffed alongside
top 8- tagApproval58 co-mentions · 29 sources
- drugHYRIMOZ26 co-mentions · 13 sources
- drugLarotid14 co-mentions · 7 sources
- drugamoxicillin14 co-mentions · 7 sources
- drugVOQUEZNA DUAL PAK14 co-mentions · 7 sources
- drugAMOXICILLIN AND CLAVULANATE POTASSIUM14 co-mentions · 7 sources
- drugVOQUEZNA TRIPLE PAK14 co-mentions · 7 sources
- drugHUMIRA13 co-mentions · 13 sources
comments(0)
5-min edit window · permanent after that